NM_003722.5:c.1212+79A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003722.5(TP63):​c.1212+79A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.499 in 1,274,402 control chromosomes in the GnomAD database, including 162,496 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.53 ( 22092 hom., cov: 30)
Exomes 𝑓: 0.50 ( 140404 hom. )

Consequence

TP63
NM_003722.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.760

Publications

16 publications found
Variant links:
Genes affected
TP63 (HGNC:15979): (tumor protein p63) This gene encodes a member of the p53 family of transcription factors. The functional domains of p53 family proteins include an N-terminal transactivation domain, a central DNA-binding domain and an oligomerization domain. Alternative splicing of this gene and the use of alternative promoters results in multiple transcript variants encoding different isoforms that vary in their functional properties. These isoforms function during skin development and maintenance, adult stem/progenitor cell regulation, heart development and premature aging. Some isoforms have been found to protect the germline by eliminating oocytes or testicular germ cells that have suffered DNA damage. Mutations in this gene are associated with ectodermal dysplasia, and cleft lip/palate syndrome 3 (EEC3); split-hand/foot malformation 4 (SHFM4); ankyloblepharon-ectodermal defects-cleft lip/palate; ADULT syndrome (acro-dermato-ungual-lacrimal-tooth); limb-mammary syndrome; Rap-Hodgkin syndrome (RHS); and orofacial cleft 8. [provided by RefSeq, Aug 2016]
TP63 Gene-Disease associations (from GenCC):
  • ADULT syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • ankyloblepharon-ectodermal defects-cleft lip/palate syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • ectrodactyly, ectodermal dysplasia, and cleft lip-palate syndrome 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • limb-mammary syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • Rapp-Hodgkin syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • premature ovarian failure 21
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • split hand-foot malformation 4
    Inheritance: AD Classification: MODERATE Submitted by: Illumina
  • EEC syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • split hand-foot malformation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 3-189869485-A-G is Benign according to our data. Variant chr3-189869485-A-G is described in ClinVar as Benign. ClinVar VariationId is 1232095.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.661 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TP63NM_003722.5 linkc.1212+79A>G intron_variant Intron 9 of 13 ENST00000264731.8 NP_003713.3 Q9H3D4-1A0A0S2Z4N5
TP63NM_001114980.2 linkc.930+79A>G intron_variant Intron 7 of 11 ENST00000354600.10 NP_001108452.1 Q9H3D4-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TP63ENST00000264731.8 linkc.1212+79A>G intron_variant Intron 9 of 13 1 NM_003722.5 ENSP00000264731.3 Q9H3D4-1
TP63ENST00000354600.10 linkc.930+79A>G intron_variant Intron 7 of 11 1 NM_001114980.2 ENSP00000346614.5 Q9H3D4-2

Frequencies

GnomAD3 genomes
AF:
0.530
AC:
80408
AN:
151790
Hom.:
22072
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.667
Gnomad AMI
AF:
0.465
Gnomad AMR
AF:
0.445
Gnomad ASJ
AF:
0.509
Gnomad EAS
AF:
0.395
Gnomad SAS
AF:
0.393
Gnomad FIN
AF:
0.403
Gnomad MID
AF:
0.682
Gnomad NFE
AF:
0.505
Gnomad OTH
AF:
0.556
GnomAD4 exome
AF:
0.495
AC:
555891
AN:
1122494
Hom.:
140404
AF XY:
0.491
AC XY:
279916
AN XY:
569828
show subpopulations
African (AFR)
AF:
0.677
AC:
17885
AN:
26434
American (AMR)
AF:
0.383
AC:
14613
AN:
38194
Ashkenazi Jewish (ASJ)
AF:
0.501
AC:
11790
AN:
23524
East Asian (EAS)
AF:
0.422
AC:
15263
AN:
36186
South Asian (SAS)
AF:
0.393
AC:
29610
AN:
75252
European-Finnish (FIN)
AF:
0.402
AC:
19508
AN:
48486
Middle Eastern (MID)
AF:
0.604
AC:
3076
AN:
5090
European-Non Finnish (NFE)
AF:
0.511
AC:
419397
AN:
820418
Other (OTH)
AF:
0.506
AC:
24749
AN:
48910
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
13502
27004
40505
54007
67509
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10770
21540
32310
43080
53850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.530
AC:
80467
AN:
151908
Hom.:
22092
Cov.:
30
AF XY:
0.520
AC XY:
38626
AN XY:
74252
show subpopulations
African (AFR)
AF:
0.667
AC:
27655
AN:
41450
American (AMR)
AF:
0.444
AC:
6774
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.509
AC:
1766
AN:
3470
East Asian (EAS)
AF:
0.395
AC:
2024
AN:
5128
South Asian (SAS)
AF:
0.394
AC:
1897
AN:
4812
European-Finnish (FIN)
AF:
0.403
AC:
4249
AN:
10546
Middle Eastern (MID)
AF:
0.671
AC:
196
AN:
292
European-Non Finnish (NFE)
AF:
0.505
AC:
34317
AN:
67940
Other (OTH)
AF:
0.554
AC:
1166
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1831
3662
5494
7325
9156
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
688
1376
2064
2752
3440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.520
Hom.:
27635
Bravo
AF:
0.541
Asia WGS
AF:
0.390
AC:
1361
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.38
DANN
Benign
0.40
PhyloP100
-0.76
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6790167; hg19: chr3-189587274; API